| NASDAQ (NMS) Exchange | US Country |
The fund is primarily focused on the healthcare and life sciences sectors, aiming to invest a considerable portion of its assets in equity and equity-related securities within these domains. This includes a wide array of investment vehicles such as common stock, options, preferred stock, and convertible debt, showing a versatile approach to capturing value across different financial instruments. The fund's strategy is not geographically limited to the United States, as it actively seeks investment opportunities globally. This is facilitated through direct investments and the use of American Depositary Receipts (ADRs), enabling participation in the performance of non-U.S. companies. The fund is designed to be adaptable in terms of the market capitalization of the companies it invests in, indicating a flexible investment approach that can span from small-cap to large-cap companies.
Primarily investing in equity securities of companies within the healthcare and life sciences sectors. This forms the core of the fund's investment strategy, targeting companies that show potential for growth or value addition in these rapidly evolving industries.
The fund extends its investment reach to equity-related securities, including options, preferred stock, and convertible debt. This diversified approach allows the fund to leverage different financial instruments to maximize returns from its focus industries.
Investment is not confined to U.S. based companies; the fund actively seeks opportunities globally. This is achieved through both direct investments in foreign companies and the use of American Depositary Receipts (ADRs), providing a broader investment horizon and access to global healthcare and life sciences markets.
The fund shows flexibility in the market capitalization of the companies in which it invests, meaning it considers investments across small, mid, and large-cap companies. This approach allows the fund to explore a wide range of investment opportunities and adapt its portfolio according to the prevailing market conditions and potential growth prospects.